Clinical Trial Update: Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

View source ↗

Summary

A non-interventional observational study sponsored by AstraZeneca to collect data on patients with transthyretin amyloidosis, including ATTR-CM and hereditary p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Transthyretin Amyloidosis with Polyneuropathy
• Transthyretin Amyloid Cardiomyopathy
• Transthyretin Amyloidosis

Snippet

Sponsor: AstraZeneca | Conditions: Transthyretin Amyloidosis, ATTR-CM | Status: RECRUITING